ECM Weekly (5th Feb 2023) - Adani, Pertamina, Hesai, Ruipeng Pet, Concord, Oasis, Flight Centre
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
394 Views
ECM Weekly (29th Jan 2023) - Adani, Oasis, Mankind Pharma, ZJLD, India IPO Bookrunners
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
402 Views
Mankind Pharma Pre-IPO - The Negatives - Recent Updates Weren't Great
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the not-so-positive aspects of the deal.
445 Views
Mankind Pharma Pre-IPO - The Positives - Diverse Portfolio with Steady past Performance
Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we talk about the positive aspects of the deal.
367 Views
Reliance Industries (Results Review Q3FY23): Earnings remain strong. Maintain ADD
Our ADD rating on Reliance Industries (RIL) with a price target of INR 2,735/sh is premised on (1) recovery in the O2C businesses
273 Views